Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,627 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
VARIAR Study: Assessment of short-term efficacy and safety of rituximab compared to an tumor necrosis factor alpha antagonists as second-line drug therapy in patients with rheumatoid arthritis refractory to a first tumor necrosis factor alpha antagonist.
Torrente-Segarra V, Acosta Pereira A, Morla R, Ruiz JM, Clavaguera T, Figuls R, Corominas H, Geli C, Roselló R, de Agustín JJ, Alegre C, Pérez C, García A, Rodríguez de la Serna A. Torrente-Segarra V, et al. Among authors: perez c. Reumatol Clin. 2016 Nov-Dec;12(6):319-322. doi: 10.1016/j.reuma.2015.11.019. Epub 2016 Jan 29. Reumatol Clin. 2016. PMID: 26831256 Free article. English, Spanish.
A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis.
Aterido A, Cañete JD, Tornero J, Blanco F, Fernández-Gutierrez B, Pérez C, Alperi-López M, Olivè A, Corominas H, Martínez-Taboada V, González I, Fernández-Nebro A, Erra A, López-Lasanta M, López Corbeto M, Palau N, Marsal S, Julià A. Aterido A, et al. Among authors: perez c. Front Immunol. 2019 Jul 2;10:1459. doi: 10.3389/fimmu.2019.01459. eCollection 2019. Front Immunol. 2019. PMID: 31312201 Free PMC article.
Dietary habits in patients with fibromyalgia: a cross-sectional study.
Almirall M, Martínez-Mateu SH, Alegre C, Collado A, Ojeda B, Arias A, Calandre EP, Hidalgo J, Carrillo MD, Huguet R, Tornero J, Alperi-López M, Fernández-Gutierrez B, Julià A, Marsal S, Arranz LI; IMIDC Project Collaborative Group. Almirall M, et al. Clin Exp Rheumatol. 2021 May-Jun;39 Suppl 130(3):170-173. doi: 10.55563/clinexprheumatol/5e0yzt. Epub 2021 Jun 21. Clin Exp Rheumatol. 2021. PMID: 34161227 Free article.
Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.
Plazas JG, Arias-Martinez A, Lecumberri A, Martínez de Castro E, Custodio A, Cano JM, Hernandez R, Montes AF, Macias I, Pieras-Lopez A, Diez M, Visa L, Tocino RV, Lago NM, Limón ML, Gil M, Pimentel P, Mangas M, Granja M, Carnicero AM, Pérez CH, Gonzalez LG, Jimenez-Fonseca P, Carmona-Bayonas A. Plazas JG, et al. Among authors: perez ch. ESMO Open. 2022 Jun;7(3):100514. doi: 10.1016/j.esmoop.2022.100514. Epub 2022 Jun 14. ESMO Open. 2022. PMID: 35714478 Free PMC article.
Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry.
Valcarcel S, Gallego J, Jimenez-Fonseca P, Diez M, de Castro EM, Hernandez R, Arrazubi V, Custodio A, Cano JM, Montes AF, Macias I, Visa L, Calvo A, Tocino RV, Lago NM, Limón ML, Granja M, Gil M, Pimentel P, Macia-Rivas L, Pérez CH, Mangas M, Carnicero AM, Cerdà P, Gonzalez LG, Navalon FG, Rambla MDM, Richard MM, Carmona-Bayonas A. Valcarcel S, et al. J Cancer Res Clin Oncol. 2023 Jul;149(7):4077-4089. doi: 10.1007/s00432-022-04294-6. Epub 2022 Aug 30. J Cancer Res Clin Oncol. 2023. PMID: 36042046
The impact of hypoalbuminemia on the long-term prognosis of patients with acute heart failure: The modifying role of carbohydrate antigen 125.
Llàcer P, Croset F, de la Espriella R, García M, Miñana G, Campos J, Santas E, Pérez C, Lorenzo M, Pérez A, Núñez G, Pérez E, Manzano L, Núñez J. Llàcer P, et al. Among authors: perez c. Eur J Intern Med. 2025 Jan 2:S0953-6205(24)00528-4. doi: 10.1016/j.ejim.2024.12.024. Online ahead of print. Eur J Intern Med. 2025. PMID: 39753436
Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later.
Rubio R, Yavlinsky A, Zamudio ME, Molinos-Albert LM, Pérez CM, Pradenas E, Canyelles M, Torres C, Tan C, Swadling L, Ramírez-Morros A, Trinité B, Vidal-Alaball J, Aguilar R, Ruiz-Comellas A, Blanco J, van Dorp L, Balloux F, Dobaño C, Moncunill G. Rubio R, et al. Among authors: perez cm. J Infect. 2024 Dec 31:106402. doi: 10.1016/j.jinf.2024.106402. Online ahead of print. J Infect. 2024. PMID: 39746406
3,627 results